Value-Dx - content and resources

Following the conclusion of the EU Project VALUE-Dx, of which ERS was a consortium partner, find all content and resources related to this project on this page.

Here, you can:

  • Download all VALUE-Dx project reports
  • View all scientific poster presentations related to VALUE-Dx
  • Access presentation content from scientific events including all VALUE-Dx general meetings
  • View all Expert Advisory Panel (EAP) meeting executive summaries
  • View all VALUE-Dx newsletters
  • Access all other associated materials

About the EU Project VALUE-Dx

VALUE-Dx is the first Innovative Medicines Initiative project initiated by 6 in vitro diagnostic companies who joined forces with 20 non-industry partners to combat antimicrobial resistance (AMR) and improve patient outcomes. Unique in its multidisciplinary consortium, it involves clinicians, microbiologists, health economists, social scientists, and industry, to help build the medical and economic case for rapid diagnostics as a public good in the fight against antibiotic resistance.

The European Respiratory Society (ERS) was a consortium member of the VALUE-Dx project and was a member of the VALUE-Dx Work Package 6 “Education and Advocacy”.

The Society’s main role within this work package was the development of the VALUE-Dx e-learning platform, which made all educational material developed by the project widely available.

However, as active member of this work package, throughout the project ERS contributed and supported all education, advocacy and communication activities developed. Also, in addition of the e-learning platform, ERS has completed the following activities:

  • Organisation of a scientific symposium at the ERS Congress yearly, to present the main progress of VALUE-Dx to the scientific community.
  • Organisation of a webinar entitled “Rapid diagnostics to revolutionise our response to respiratory infections: Fighting Antimicrobial Resistance”
  • Writing of a scientific statement on the role rapid diagnostic tests (RDT) for the diagnosis and management of community-acquired acute low respiratory tract infections (CA-LRTI).

World Antibiotic Awareness Week - campaign materials

World Antibiotic Awareness Week is a campaign that is held in November and was initiated by WHO.

It now involves initiatives and organisations all over the world that are committed to tackling antibiotic resistance through raising global awareness on proper handling of antibiotics and sharing good practices.

VALUE-Dx campaign - World Antibiotic Awareness Week 2023

VALUE-Dx - publications

VALUE-Dx - scientific poster presentations

Antibiotic resistance and respiratory infections - Preview Image

Antibiotic resistance and respiratory infections

2019 infographic. View the full poster.


View in full
ADEQUATE flyer - Preview Image

ADEQUATE flyer

Advanced Diagnostics for Enhanced QUality of Antibiotic prescription in respiratory Tract infections in Emergency rooms. View the full poster.


View in full
Health-Economics Modelling of Infectious Disease Diagnostics: current approaches and future opportunities - Preview Image

Health-Economics Modelling of Infectious Disease Diagnostics: current approaches and future opportunities

Presented at ISPOR Europe 2019, Copenhagen, Denmark. View the full poster.


View in full

E-learning resources

View all VALUE-Dx e-learning resources on the ERS Respiratory Channel